Evidence map›Paper›PMID 30320205›Full record

ArticleAdvanced therapeutics2018

Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against

Pavimol Angsantikul, Soracha Thamphiwatana, Qiangzhe Zhang, Kevin Spiekermann, Jia Zhuang, Ronnie H Fang, Weiwei Gao, Marygorret Obonyo, Liangfang Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced therapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Opportunities forMicroorganisms · 2024
    Review
  16. Review
  17. Review
  18. Review
  19. Convergence of Nanotechnology and Bacteriotherapy for Biomedical Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pavimol AngsantikulDepartment of NanoEngineering and Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
Soracha ThamphiwatanaDepartment of NanoEngineering and Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
Qiangzhe ZhangDepartment of NanoEngineering and Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
Kevin SpiekermannDepartment of NanoEngineering and Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
Jia ZhuangDepartment of NanoEngineering and Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
Ronnie H FangDepartment of NanoEngineering and Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
Weiwei GaoDepartment of NanoEngineering and Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
Marygorret ObonyoDepartment of Medicine, University of California San Diego, La Jolla, CA 92093, USA.
Liangfang ZhangDepartment of NanoEngineering and Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.

Funding

Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma MetastasisR01CA200574 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LI, SHULIN, ZHANG, LIANGFANG · 2016 to 2020
$1.8M
Innate Antimicrobial Nanotherapeutics for the Treatment of H. pylori InfectionR01DK095168 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZHANG, LIANGFANG · 2012 to 2016
$1.6M
NCI NIH HHS R01 CA200574NIDDK NIH HHS R01 DK095168
6 · The paper itself

Abstract

Inspired by the natural pathogen-host interactions and adhesion, this study reports on the development of a novel targeted nanotherapeutics for the treatment of

Indexed as

active targetingantimicrobial deliverybacterial infectionbiomimetic nanoparticlenanomedicine

Identifiers

PMID30320205
PMCPMC6176867

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.